Abstracts tagged "neuropathy"

Abstract Number: 1904 • ACR Convergence 2021
“Why Does My Knee Hurt After I Got My Knee Replaced?”: Evaluation of Neuropathic-like Symptoms and Objective Signs of Neuropathy Post-Knee Replacement in Patients with Knee Osteoarthritis
Devin Driscoll¹, Priyanka Ballal¹, Na Wang², Laura Frey-Law³, Cora Lewis⁴, Michael Nevitt⁵ and Tuhina Neogi¹, ¹Boston University School of Medicine, Boston, MA, ²Boston University, Boston, MA, ³University of Iowa, Iowa City, IA, ⁴University of Alabama Birmingham, Birmingham, AL, ⁵University of California San Francisco, Orinda, CA
Background/Purpose: Some people with knee osteoarthritis (OA) have persistent pain post-knee replacement, but why this occurs is not fully understood. One possibility is post-surgical neuropathy.…
Abstract Number: 1601 • 2019 ACR/ARP Annual Meeting
Prevalence of Peripheral Neuropathy and Its Electrophysiological Types in Patients with Systemic Lupus Erythematosus
Cynthia Matilda Wendo¹, George Oyoo ¹, Thomas Otieno Kwasa ¹, Marybeth Maritim ¹, Sybil Nakitare ² and Judith Kwasa ¹, ¹University of Nairobi, Nairobi, Kenya, ²Kenyatta National Hospital, Nairobi, Kenya
Background/Purpose: Peripheral neuropathy (PN), one of the neuropsychiatric syndromes of SLE, occurs in 2% to 36% of patients. It has been associated with high disease…
Abstract Number: 457 • 2018 ACR/ARHP Annual Meeting
Neuropathic Pain in Patients with Knee Osteoarthritis (Preliminary Report)
Pinar Borman¹, Ferda Kaygisiz² and Aysegul Yaman³, ¹Department of Physical Medicine and Rehabilitation, University of Hacettepe Faculty of Medicine, Ankara, Turkey, ²Dept of PMR, Ankara Training and Research Hospital, Ankara, Turkey, ³Dept of PMR, University of Hacettepe Faculty of Medicine, Ankara, Turkey
Background/Purpose: There are limited studies in the literature indicating that neuropathic pain occurs in knee osteoarthritis (OA) (1). The aim of this cross sectional study…
Abstract Number: 731 • 2018 ACR/ARHP Annual Meeting
Clinical Characteristics and Neurophysiological Patterns of Peripheral Neuropathies in Patients with Systemic Lupus Erythematosus: A Single Center Experience
Francisco Treviño-Tello¹, Erwin Chiquete², Christopher Cabib², Ariadna Díaz-Mora¹, Mariana Lopez-Lopez¹, Ivonne Sandoval-Flores¹, Juan José Gómez-Piña² and Hilda Fragoso-Loyo¹, ¹Immunology and Rheumatology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico, ²Neurology and Neuropsychiatry, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico
Background/Purpose: The prevalence of peripheral neurological manifestations in Systemic Lupus Erythematosus (SLE) ranges between 5% and 27% and are a major cause of morbidity. The…
Abstract Number: 1920 • 2018 ACR/ARHP Annual Meeting
Is There Objective Evidence of Neuropathy in Knee Osteoarthritis Based on Clinical Evaluation?
Priyanka Ballal¹, Joachim Scholz², Laura Frey-Law³, Na Wang¹, Michael C. Nevitt⁴, Cora E. Lewis⁵ and Tuhina Neogi⁶, ¹Boston University School of Medicine, Boston, MA, ²Departments of Anesthesiology and Pharmacology, Columbia University Medical Center, New York, NY, ³University of Iowa, Iowa City, IA, ⁴Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, ⁵University of Alabama Birmingham, Birmingham, AL, ⁶Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA
Background/Purpose: Self-reported descriptors of pain in knee osteoarthritis (OA) such as burning and stabbing pain are suggestive of a neuropathic component of pain beyond that…
Abstract Number: 49 • 2016 ACR/ARHP Annual Meeting
Efficacy of Mirogabalin on Patient-Reported Pain and Sleep Interference in Patients with Diabetic Neuropathic Pain: Secondary Outcomes of a Phase 2 Proof-of-Concept Study
Domenico Merante¹, Julio Rosenstock², Uma Sharma³, Karen Feins⁴, Ching Hsu⁵ and Aaron Vinik⁶, ¹Daiichi Sankyo Development Ltd, Gerrards Cross, Buckinghamshire, United Kingdom, ²Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX, ³MMS Holdings Inc., Canton, MI, ⁴Daiichi Sankyo Pharma Development, Edison, NJ, ⁵Daiichi Sankyo Inc, Edison, NJ, ⁶Eastern Virginia Medical School, Norfolk, VA
Background/Purpose: Mirogabalin is a novel, preferentially selective a2d-1 ligand intended for treatment of pain associated with fibromyalgia and neuropathic pain. Mirogabalin efficacy and safety was…
Abstract Number: 1434 • 2015 ACR/ARHP Annual Meeting
Neuropathic Pain in Patients with Rheumatoid Arthritis: Relation with Clinical Variables
Ferda Kaygisiz¹, Pinar Borman² and Aynur Karagoz³, ¹Dept of Physical Medicine and Rehabilitation, Ankara Training and Research Hospital, Ankara, Turkey, ²Department of Physical Medicine and Rehabilitation, University of Hacettepe Faculty of Medicine, Ankara, Turkey, ³Dept of Physical Medicine and Rehabilitation, Ministry of Health, Ankara Training and Research Hospital, Ankara, Turkey
Background/Purpose: There are few studies in the literature indicating that neuropathic pain occurs in rheumatoid arthritis (RA). The aim of this cross sectional study was…
Abstract Number: 1872 • 2015 ACR/ARHP Annual Meeting
Symptomatic and Electrodiagnostic Features of Peripheral Neuropathy in Scleroderma
Julie J. Paik¹, Andrew Mammen², Fredrick M. Wigley³, Ami A. Shah⁴, Laura K. Hummers⁵ and Michael Polydefkis⁶, ¹Rheumatology, Johns Hopkins University, Baltimore, MD, ²Center Tower Ste 5300, Johns Hopkins University School of Medicine, Baltimore, MD, ³Rheum Div/Mason F Lord, Johns Hopkins University School of Medicine, Baltimore, MD, ⁴Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ⁵Johns Hopkins University School of Medicine, Baltimore, MD, ⁶Neurology, Johns Hopkins University, Baltimore, MD
Title: Symptomatic and electrodiagnostic features of peripheral neuropathy in scleroderma Background/Purpose: Peripheral neuropathy in scleroderma has been poorly characterized and the prevalence is unknown. The…
Abstract Number: 894 • 2014 ACR/ARHP Annual Meeting
Small Fiber Neuropathy in Women with Fibromyalgia. a Clinical-Pathological Correlation Using Confocal Corneal Biomicroscopy
Manuel Ramírez-Fernández¹, Laura-Aline Martinez-Martinez², Angelica Vargas-Guerrero³, Manuel Martínez-Lavín⁴, Everardo Hernandez Quintela¹ and Jorge Velazco-Caspia¹, ¹Asociación para Evitar la Ceguera en México, Mexico City, Mexico, ²Instituto Nacional de Cardiologia, Mexico City, Mexico, ³Rheumatology, Instituto Nacional de Cardiologia, Mexico City, Mexico, ⁴Chief Rheumatology, Instituto Nacional de Cardiologia, Mexico City, Mexico
Background/Purpose: A consistent line of investigation proposes that fibromyalgia is a sympathetically maintained neuropathic pain syndrome (Semin Arthritis Rheum 2000;29:197). This view has been recently reinforced…
Abstract Number: 253 • 2014 ACR/ARHP Annual Meeting
Evaluating Neuropathic Complaints By DN4 and Lanss Scales after Local Corticosteroid Therapy in Carpal Tunnel Syndrome
Taner Dandinoglu¹, Murat Karadeniz², Volkan Yılmaz³, Levent Tekin⁴ and Ümit Dinçer⁴, ¹Physical Medicine and Rehabilitation, Bursa Military Hospital, Bursa, Turkey, ²Physical Medicine and Rehabilitation, Çorlu Military Hospital, Tekirdağ, Turkey, ³Physical Medicine and Rehabilitation, Mevki Military Hospital, Ankara, Turkey, ⁴Physical Medicine and Rehabilitation, Gülhane Military Medical Academy, Haydarpaşa Training Hospital, İstanbul, Turkey

Background/Purpose: The purpose of this study was to evaluate the neuropathic symptoms after local steroid injection in CTS. Since 2001, neuropathic pain scales have…
Abstract Number: 246 • 2014 ACR/ARHP Annual Meeting
Neuropathic PAIN in Patients with Ankylosing Spondylitis
Pinar Borman¹, Ferda Kaygisiz², Aysegul Yaman¹ and Aynur Karagoz², ¹Department of Physical Medicine and Rehabilitation, University of Hacettepe Faculty of Medicine, Ankara, Turkey, ²Clinic of Physical Medicine and Rehabilitation, Ankara Training and Research Hospital, Ankara, Turkey
Background/Purpose: There is only one study in the literature indicating that neuropathic pain occurs in ankylosing spondylitis (AS) (1). Methods: The aim of this cross…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].